找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines

[復(fù)制鏈接]
查看: 12348|回復(fù): 55
樓主
發(fā)表于 2025-3-21 16:55:48 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Immunosuppression under Trial
副標(biāo)題Proceedings of the 3
編輯P. Cochat,J. Traeger,M. Derchavane
視頻videohttp://file.papertrans.cn/463/462291/462291.mp4
叢書名稱Transplantation and Clinical Immunology
圖書封面Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines
描述Immunosuppression in solid organ transplantation is currentlyexperiencing a worldwide revival since new drugs are now available andothers are under development. In order to contribute to the design offuture strategies, a critical approach of surrogate endpoints is givenand long-term side effects are analysed, together with the impact ofnon-compliance, quality-of-life and economical parameters. In thisbook, international specialists have set up the scientific rationaleand provided new bases for further immunosuppressive strategies.
出版日期Conference proceedings 1999
關(guān)鍵詞cancer; clinical trial; immunosuppression; kidney; transplantation
版次1
doihttps://doi.org/10.1007/978-94-011-4643-2
isbn_softcover978-94-010-5960-2
isbn_ebook978-94-011-4643-2
copyrightSpringer Science+Business Media Dordrecht 1999
The information of publication is updating

書目名稱Immunosuppression under Trial影響因子(影響力)




書目名稱Immunosuppression under Trial影響因子(影響力)學(xué)科排名




書目名稱Immunosuppression under Trial網(wǎng)絡(luò)公開度




書目名稱Immunosuppression under Trial網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Immunosuppression under Trial被引頻次




書目名稱Immunosuppression under Trial被引頻次學(xué)科排名




書目名稱Immunosuppression under Trial年度引用




書目名稱Immunosuppression under Trial年度引用學(xué)科排名




書目名稱Immunosuppression under Trial讀者反饋




書目名稱Immunosuppression under Trial讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:31:27 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:28:08 | 只看該作者
Minimal standards for reporting clinical trial results in transplantationbenefit of that therapy. Not all therapeutic decisions in medicine are based on the results of clinical trials. For example, insulin is the standard treatment of diabetic ketoacidosis, even though this therapy was never tested in a randomized controlled trial. Similarly, the need to use immunosuppre
地板
發(fā)表于 2025-3-22 06:42:42 | 只看該作者
5#
發(fā)表于 2025-3-22 09:33:29 | 只看該作者
6#
發(fā)表于 2025-3-22 13:18:48 | 只看該作者
7#
發(fā)表于 2025-3-22 17:50:43 | 只看該作者
Factors influencing long-term allograft survival the steady attrition of transplanted organs due to chronic rejection. The UNOS published half-life for cadaveric renal allografts is approximately 8.5 years, not significantly different from the 7.7 year half-life published for cadaveric renal allografts under azathioprine-prednisone immunosuppress
8#
發(fā)表于 2025-3-22 23:40:26 | 只看該作者
9#
發(fā)表于 2025-3-23 04:57:48 | 只看該作者
Cardiovascular complications after renal transplantation than 49.2% by death with a functioning graft, while other causes account for a further 9.4%. Thus, reduction of cardiovascular death will be a very efficient measure to preserve grafts. According to the EDTA Registry [2], the frequency of death from cardiovascular causes increases markedly with age
10#
發(fā)表于 2025-3-23 06:28:36 | 只看該作者
Strategies to minimize nephrotoxicity associated to calcineurin inhibitorsclosporine and tacrolimus has been reported [1–3]. Mihatsch et al. [4] found that the side effect pattern of these drugs is nearly identical: they were unable to differentiate morphological changes associated with their clinical nephrotoxicity.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 20:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
玉田县| 馆陶县| 松江区| 昆明市| 洛浦县| 类乌齐县| 安宁市| 确山县| 固始县| 密山市| 德令哈市| 民丰县| 喀喇沁旗| 海城市| 鹤庆县| 富裕县| 宁蒗| 南城县| 霍城县| 金沙县| 清丰县| 怀安县| 山阳县| 石台县| 淳化县| 饶阳县| 枝江市| 富民县| 思茅市| 宝山区| 济源市| 石狮市| 文山县| 龙州县| 简阳市| 汉阴县| 九龙县| 宜章县| 陆河县| 临高县| 微山县|